The failure of EVs derived from low-metastatic DGC cells to induce chemokines under TGF-β treatment indicates that EVs derived from high-metastatic cancer cells have a potent capacity to generate the fibroblast subpopulation with chemokine expression. The gene discussed is TGFB1; the disease is cancer.